Exelixis, Inc. today announced its preliminary unaudited financial results for the fiscal year 2025, provided financial guidance for fiscal year 2026 and delivered an update on its business. Exelixis ...
Preliminary 2025 net product revenue of $155.4 million, representing 172% year-over-year growth; OJEMDA 2026 U.S. net product ...
Krish S. Krishnan, Chairman and Chief Executive Officer, and Suma M. Krishnan, President of Research and Development, will ...
Positive Phase 3 HERIZON-GEA-01 results for Ziihera® (zanidatamab-hrii) in first-line HER2-positive (HER2+) gastroesophageal ...
Detailed price information for Stallion Uranium Corp (STUD-X) from The Globe and Mail including charting and trades.
REGENXBIO Inc. highlighted progress and upcoming anticipated milestones across its pipeline of AAV gene therapies for rare and retinal diseases. "2026 is set to be a transformative year for REGENXBIO, ...
PLEASANTON, Calif., Jan. 11, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial ...
Positive Phase 3 HERIZON-GEA-01 results for Ziihera (zanidatamab-hrii) in first-line HER2-positive (HER2+) gastroesophageal adenocarcinoma (GEA) presented at ASCO GI Up to $440.0 million in milestone ...
Follow live updates as Nikki Glaser hosts the 2026 Golden Globes. See red carpet looks from this year’s nominees and follow ...
IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a leading precision medicine oncology company, provided a business update including ...
Trade Desk's growth catalysts include Connected TV and Joint Business Plans, but market leaders, like GOOG and AMZN, dominate ...
Triggered by the unprecedented demand of German State Premier Daniel Günther (CDU) for censorship and media bans, Google's AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback